Replies to post #457576 on NorthWest Biotherapeutics Inc (NWBO)

[CrashOverride]

We know the FDA didn't reject the SAP and it was accepted by European regulators. As much as it can be frustrating to wish your brokerage account was 10-100X higher than it is today that doesn't mean we won't see that occur when it's supposed to happen. Good luck to you and all the patient longs!

[biosectinvestor]

They can do the industry expert theater, which they did last time, without having to delay. I don' t see them delaying for a conference because that is not what they've said they would do and I think they have even said that was not the plan when asked. I think ASCO is great because they can be in any big journal, commandeer the Industry Expert Theater for an hour, in a large group, as they have 2 times before, and boom, instant audience.

Additionally, they may have information at that point on DCVax Direct or a combination trial that they can do an official conference talk/release about if they really, really want to do something just for a conference that is novel. I hope they are not delaying release of TLD for ANY reason at this point. No need to do it.

[MI Dendream]

You can have more than one presentation and publication. The ECA validation is one. Deep dive into Efficacy and Safety can be separated from TLD plenary presentation during secondary platform presentations….done all of the time.

We will have data by or during ASCO IMHO. Last chance to load up.

[newman2021]

ASM will have o be scheduled by June 18 if they meet the SEC guidelines. In that case, ASM invites need to be sent out a month advance. So, we should see good news before ASCO is my prediction, imo. We are close, very close, any day for good news I guess!